Marrakesh, Morocco 12-05-2026
Degenerative joint disease (DJD), commonly referred to as osteoarthritis, is a leading cause of disability worldwide. Increasing evidence highlights the interconnected roles of endocrine disorders and obesity in both the onset and progression of DJD. Endocrine dysfunction, including hypothyroidism, Cushing’s syndrome, and polycystic ovary syndrome (PCOS)contributes to metabolic dysregulation and weight gain, which in turn accelerates joint degeneration through mechanical overload, chronic inflammation, and altered adipokine signaling. Nutritional factors further modulate these processes by influencing systemic inflammation, oxidative stress, and cartilage integrity. This review synthesizes current evidence on the pathophysiological links among endocrine disorders, obesity, and DJD, and emphasizes the importance of integrated clinical management strategies targeting hormonal balance, weight reduction, and dietary optimization. A multidisciplinary approach is essential to mitigate disease progression and improve patient outcomes.
Keywords - Osteoarthritis; Degenerative Joint Disease; Obesity; Endocrine Disorders; Inflammation; Metabolism